Acesion Pharma

Recent Finacing

Series B

Recent Raise

$47.7M

Acesion Pharma is a biotech company that develops therapies for atrial fibrillation, specifically focusing on the clinical development of an SK ion channel inhibitor for chronic oral treatment.